MedTrace Logo

Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon

NCT01604148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2012-05-23

No results posted yet for this study

Summary

Persistent detrusor overactivity (DO) after transurethral prostatectomy results in symptomatic failure in more than one third of the patients. Storage symptoms are major complaints in the early postoperative period after Holmium Laser Enucleation of the Prostate (HoLEP). To investigate the effect of DO in the patients with Benign Prostatic Obstruction (BPO), the investigators evaluated the changes in the storage symptoms following HoLEP in conjunction with the prescription of the anticholinergic drugs.

Conditions

  • Lower Urinary Tract Symptoms
  • Benign Prostatic Hyperplasia

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Kyu-Sung Lee, Ph.D, M.D. · Samsung Medical Center

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604148 on ClinicalTrials.gov